Trump’s tariffs hit markets hard, wiping billions off the ASX, while gold soars and China and the EU gear up for retaliation.

Liberation Day did not deliver punitive tariffs on the pharmaceutical sector - but the reprieve could be short lived.

Argent BioPharma’s (ASX:RGT) flagship cannabinoid-based therapy for refractory epilepsy has been approved for prescription in ...

Legacy Minerals (ASX:LGM) has assayed drill core from 2011 at the Thomson project in NSW, recording up to 6.73g/t gold.

Trump’s tariffs have hit global exports, with China copping it hardest and Australia facing a 10pc levy. Meanwhile, gold hits record highs.

Special report: A maiden drilling campaign is set to start at Bubalus Resources’ Crosbie South gold-antimony prospect in Victoria thanks to a recent $1.5 million raise.

The rejection by Galan Lithium of a US$150 million bid for its Argentine assets has pleased investors with shares up as much as 52.4%.

ASX tech took a hit with global chaos while Opyl, Yojee, and RocketBoots made moves, but big Wall Street names are struggling with AI.

A golden run for the popular precious metal has sent it soaring to record highs, and investors seeking a slice have several options.

Chinese export controls have thrown the doors open for ASX tungsten players to supply the military metal to the West.

RareX was the fastest growing ASX resources stock in March with a gallium find at Cummins Range, but gold stocks dominated.

Fintechs are using AI and alternative data to speed up loan approvals, making credit more accessible to those overlooked by traditional banks.